glycoprotein. The technique revealed that the immature form of the myelin-associated glycoprotein with a slightly larger apparent molecular weight also bound concanavalin A, and that in purified immature rat myelin the quantitative importance of some of the other glycoproteins in binding concanavalin A was increased relative to the myelin-associated glycoprotein. The separated proteins of bovine and human myelin bound more [3H]-concanavalin A than those of rat myelin. In these species, the myelin-associated glycoprotein was a major concanavalin A-binding protein, although two higher-molecularweight glycoproteins also bound significant quantities of [3H] concanavalin A. The results indicate that there are receptors for concanavalin A on the surface of rat, bovine and human myelin membranes and suggest that the myelin-associated glycoprotein is one of the principal receptors.
Lectins have been widely used in the study of cellsurface membrane glycoproteins Nicolson, 1974) . They are particularly useful in the study of brain tissue as cell-surface carbohydrates may have an important role in cell-cell interactions during the formation of the neuronal network. The most commonly used lectin in these studies is concanavalin A. Concanavalin A-binding glycoproteins and glycopeptides have been isolated from whole rat and human brain by affinity chromatography (Gombos et al., 1972; Susz et al., 1973; Brunngraber et al., 1975; Zanetta et al., 1977) . Concanavalin A has also been shown to bind to several different structures in central-nervous-system synapses (Matus et al., 1973; Bittiger & Schnebli, 1974; Zanetta et al., 1975; Gurd, 1977) . In the peripheral nervous system, concanavalin A binds to the intraperiod line of myelin (Wood & McLaughlin, 1975) , and this also appears to be the case in central-nervous-system myelin (Matus et al., 1973) although concanavalin A molecules have only been visualized on exposed surfaces of isolated myelin fragments. In addition, Matthieu et al. (1974) demonstrated that purified rat central-nervous-system myelin could be agglutinated with concanavalin A. A postulated receptor Vol. 183 molecule for concanavalin A in rat central-nervoussystem myelin is the major myelin-associated glycoprotein (Quarles et al., 1973 a;  Quarles, 1979) .
Techniques have been developed for identifying molecules potentially involved in the binding of lectins to cell membranes. The membrane glycoproteins are separated by polyacrylamide/sodium dodecyl sulphate-gel electrophoresis and the lectinbinding proteins are identified by their reaction with radioactively-or peroxidase-labelled lectin, which is diffused into the gel (Wood & Sarinana, 1975; Robinson et al., 1975; Tanner & Anstee, 1976; Gurd & Evans, 1976; Burridge, 1976; Rostas et al., 1977) .
An understanding of the surface structure of myelin at the molecular level is particularly important because of immune processes or viral interactions that may occur in pathological states such as multiple sclerosis. For this reason it was decided to identify potential concanavalin A receptors in rat centralnervous-system myelin by the binding of 3H-labelled lectin after separation of myelin proteins by polyacrylamide/sodium dodecyl sulphate-gel electrophoresis. It was also decided to investigate whether changes occurred in lectin binding to myelin during development and if there are species differences. A second reason for studying the binding of [3H]-concanavalin A to myelin on polyacrylamide/sodium dodecyl sulphate gels was to determine whether this would provide a sensitive method of detecting myelin glycoproteins when extrapolating studies with rat myelin labelled in vivo with radioactive isotopically labelled sugars to unlabelled human myelin. Initially, aggutination assays were carried out on purified myelin fragments from several species to determine whether or not they had receptors for concanavalin A. The following paper of 0.9 % (w/v) NaCl under mild anaesthesia (Quarles etal., 1973a) . The rats were killed 16-20 h later and the brains were rapidly removed and taken for the purification of myelin.
Purification ofmyelin
In the purification of bovine and human myelin, areas rich in white matter were dissected from the brain and used as the starting material. In all cases myelin was prepared essentially by the procedure of Norton & Poduslo (1973) . Freshly prepared myelin was used for the agglutination studies by the procedure described in the next section, or the myelin was freeze-dried and stored under vacuum at -20°C until used later for polyacrylamide-gel electrophoresis.
Agglutination of isolated myelin fragments
The ability of concanavalin A to agglutinate purified myelin was determined essentially as described previously (Matthieu et al., 1974 (Matthieu etal., 1974) .
Polyacrylamide-gel electrophoresis Before electrophoresis, the freeze-dried myelin was delipidated by extracting it three times with diethyl ether/ethanol (3:2, v/v) and once with diethyl ether (Greenfield et al., 1971) or by treating it with chloroform/methanol (2: 1, v/v; Quarles et al., 1973a) . The insoluble residue was centrifuged out of the chloroform/methanol at 105000g, washed once with diethyl ether and dried under N2. In both cases the proteins were solubilized in 1 % sodium dodecyl sulphate by heating at 100°C for 3 min in the presence of 0.15 M-dithiothreitol. Samples (500,ug) of protein were electrophoresed on 5 % (w/v) polyacrylamide gels (6 mm x 100 mm) as previously described (Quarles & Brady, 1971) . When it was required, gels were stained for glycoprotein by the periodate/Schiff method (Segrest & Jackson, 1972) .
Concanavalin A binding
After electrophoresis, the 5% sodium dodecyl sulphate gels were reacted with [3H]concanavalin A by using basically the method of Gurd & Evans (1976) . The gels were washed with 25 % propan-2-ol/ 10% acetic acid for 8h with one change and then with 10% propan-2-ol/10% acetic acid for 16h. The gels were then washed with 5mM-Tris/HC1, pH7.6, for 4 h with four changes. All the washes were carried out at 4°C. Each gel was then incubated overnight at 24°C in 5mM-Tris/HC1, pH7.6, to which had been 1979 added 100,ul (16.8,ug) 
concanavalin A was then removed by washing the gels three times with 250ml per gel of 5 mM-Tris/HCI, pH 7.6, at 4°C over at least a 3 h period. In the case of control gels 2.5 % methyl a-Dmannopyranoside was dissolved in the labelling and washing solutions. The gels were then sliced in 2mm sections with a Mickle gel slicer and the radioactivity in each section was determined by using method B of Quarles et al. (1973a) . In some experiments smaller amounts of both protein and [3H]concanavalin A and shorter incubation times were used.
Results

Agglutination ofpurified myelin fragments
Addition of concanavalin A to suspensions of freshly prepared adult or immature rat brain myelin caused the formation of large clumps that rapidly settled to the bottom of the tube (Table 1 ). This strong agglutination was prevented by methyl a-mannoside, but not by methyl a-galactoside. Adult bovine and human brain myelin were also agglutinated by concanavalin A, and again the agglutination was only inhibited by the lectin-specific sugar methyl amannoside. However, in these cases the agglutination was much weaker than for the rat brain myelin (Table  1 ). The much lower capacity for bovine and human myelin to be agglutinated by concanavalin A was also evident when the samples were examined by Nomarski interference microscopy. Although there were some aggregates of bovine and human myelin fragments in the concanavalin A-treated samples that were larger than those in the controls, they were much smaller than the very large aggregates seen in the similarly treated rat myelin. (Quarles et al., 1973a; . For this reason the [3H]concanavalin A binding was repeated by using diethyl ether/ethanol-delipidated myelin. Little protein is lost during this extraction process. In this case unlabelled rat myelin was used as insufficient 14C radioactivity could be put on the gel to give meaningful results. The position of the myelin-associated glycoprotein was determined from identical gels stained by the periodate/Schiff method. (It was found that this stain could not be used on the same gel as the concanavalin A binding.) As with chloroform/methanol-extracted myelin, it is apparent that the major concanavalin A-binding protein in diethyl ether/ethanol-extracted myelin is the myelinassociated glycoprotein (Fig. lb) Vol. 183 strate molecular-weight differences between the myelin-associated glycoprotein of a particular sample and a radioactively labelled marker myelinassociated glycoprotein.
The binding of concanavalin A to bovine and human myelin
The binding of [3H]concanavalin A was also carried out on 5 % polyacrylamide gels of bovine and human myelin that had been delipidated with chloroform/ methanol. Fig. 4(a) shows the pattern of radioactivity obtained with bovine myelin. As with adult rat myelin the myelin-associated glycoprotein binds more [3H]concanavalin A than any of the other glycoproteins in bovine myelin. In this case, however, the minor concanavalin A-binding components with a molecular weight higher than the myelin-associated glycoprotein are more pronounced. The results of binding [3H]concanavalin A to a gel of human myelin are shown in Fig. 4(b) . Human myelin appears to have three glycoproteins that bind concanavalin A in about equal amounts. One of the peaks coincides with the position of the myelin-associated glycoprotein. The two other peaks electrophorese in about the same area as the two high-molecular-weight minor components observed in bovine and rat myelin. A further feature of the human myelin reaction with concanavalin A is that there appears to be a much 
Discussion
Previous studies have shown that ferritin-concanavalin A binds to fragments ofrat central-nervoussystem myelin (Matus et al., 1973) and that concanavalin A strongly agglutinates suspensions of myelin purified from adult rat brain (Matthieu et al., 1974) . The current studies show that myelin from immature rat brain is also strongly agglutinated, and that mature bovine and human myelin are agglutinated but less effectively than rat myelin (Table 1) . It was previously suggested that the myelin-associated glycoprotein could be involved in the binding of lectins to central-nervous-system myelin (Matthieu et al., 1974) . The present paper identifies the myelin-associated glycoprotein as a major concanavalin A-binding glycoprotein in myelin, when either chloroform/methanol or diethyl ether/ethanol-extracted myelin was examined (Fig. 1) . It is interesting to note that the amount of concanavalin A radioactivity bound/mg of protein in diethyl ether/ethanol-extracted myelin was 20-25% of that obtained with chloroform/methanol-extracted myelin. This correlates well with the fact that the latter method of extraction removes 75-80% of the myelin protein, but little of the glycoproteins (Quarles et al., 1973a) .
The binding of concanavalin A to the myelinassociated glycoprotein indicates that the glycoprotein contains mannose or glucose residues. It has also been shown to contain galactose (Poduslo et al., 1976) and is the major myelin protein component that is labelled when radioactive Na2SO4 (Matthieu et al., 1975) , fucose, glucosamine or N-acetylmannosamine, a sialic acid precursor, are incorporated in vivo (Quarles et al., 1973a) .
The facts that the myelin-associated glycoprotein appears to be a major concanavalin A receptor and that isolated myelin can be agglutinated by using the lectin suggest that carbohydrate moieties of the glycoprotein are exposed to some extent in the disrupted fragments of myelin that are purified. Previous surface-labelling studies with galactose oxidase led to the conclusion that the myelin-associated glycoprotein is also at least partially exposed on the external surface of the myelin sheath or closely related membranes in situ (Poduslo et al., 1976) , although a recent immunocytochemical investigation indicates that this glycoprotein is particularly concentrated in the portion of the myelin sheath adjacent to the axon (Sternberger et al., 1979) . It is likely that the myelin-associated glycoprotein in the latter location would also be exposed in the isolated fragments of myelin. In the periaxonal location the myelin-associated glycoprotein is well situated to be involved in glial-axonal interactions occurring during myelinogenesis, and it is conceivable that such an interaction could involve a lectin-like molecule of the type now being detected in mammalian tissues (Simpson et al., 1978) . When [3H]concanavalin A was bound to immature rat myelin on polyacrylamide/sodium dodecyl sulphate gels it was found that the myelin-associated glycoprotein was no longer the only major lectin receptor, but there were several principal concanavalin Abinding proteins present in the membrane (Fig. 2) . Lectin labelling of sodium dodecyl sulphate gels has also been used to detect changes in membrane-surface glycoproteins during transformation (Burridge, 1976) and differentiation (Light & Tanner, 1977) . In the course of development, changes in membrane glycoproteins have been demonstrated in chick erythrocytes (Weise & Ingram, 1976) . The differences in concanavalin A binding between immature and mature myelin may be significant in understanding the mechanism of progression from myelin, which has one or two loose turns around the axon, to a highly compact multilamellar structure.
In the peripheral nervous system there is also a glycoprotein in purified myelin, although, in this case, it is a major component of the membrane (Everly et al., 1973; Wood & Dawson, 1973) . This glycoprotein also binds concanavalin A and peroxidasetagged concanavalin A can be visualized at the intraperiod line of the myelin sheath (Wood & McLaughlin, 1975) . Recent immunocytochemical studies indicate that a small amount of the myelinassociated glycoprotein, or an antigenically similar glycoprotein, is also present in peripheral myelin (Sternberger et al., 1979 (Fig. 3) , it provides a sensitive method of studying the myelin-associated glycoprotein in tissues that cannot be labelled in vivo with radioactive sugar precursors, especially human myelin. The differences in the pattern of binding of [3H]-concanavalin A to gels of bovine and human myelin in comparison with rat myelin (Fig. 4) are similar in some respects to the differences observed previously by periodate/Schiff staining of such gels . Both techniques indicate that human myelin has a higher proportion of other glycoproteins relative to the myelin-associated glycoprotein. Both methods indicate that bovine myelin is intermediate between human and rat myelin in this respect. However, in absolute terms, human and bovine myelin-associated glycoprotein bound more radioactive concanavalin A than rat myelin-associated glycoprotein, whereas they stained less intensely with periodate/Schiff reagents . This might be explained by a lower content of sialic acid-rich terminal oligosaccharide units in the human and bovine myelin-associated glycoprotein, which would decrease the periodate/Schiff staining, but could increase the concanavalin A binding to internal mannose residues. The greater binding of concanavalin A to the solubilized proteins of human and bovine myelin than to those of rat myelin does not correlate directly with substantially weaker agglutination of human and bovine myelin, but this might be explained by inaccessibility of the binding sites in the intact myelin membranes of these species.
In conclusion, these studies have shown that concanavalin A-binding sites are exposed on purified myelin membranes of three different species, including humans. [3H]Concanavalin A binding to myelin proteins separated on sodium dodecyl sulphate gels has shown that the myelin-associated glycoprotein is likely to be a major receptor for this lectin in each species. In addition, it appears that this method may prove very useful in the study of glycoproteins in human myelin samples when material is limited. The following paper considers the binding of rat myelin glycoproteins to immobilized concanavalin A as well as the interactions of other lectins with purified myelin fractions and solubilized myelin proteins.
